168 related articles for article (PubMed ID: 8937493)
1. [Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)].
Fukuoka M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1825-32. PubMed ID: 8937493
[TBL] [Abstract][Full Text] [Related]
2. [A late phase II study of LY188011 (Gemcitabine hydrochloride) in patients with non-small-cell lung cancer. Gemcitabine Cooperative Study Group B for Late Phase II].
Yokoyama A; Nakai Y; Yoneda S; Kurita Y; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1681-8. PubMed ID: 8886045
[TBL] [Abstract][Full Text] [Related]
3. [LY188011 phase I study. Research Group of Gemcitabine (LY188011)].
Taguchi T; Furuse K; Fukuoka M; Shimoyama T; Morimoto K; Nakamura T; Furue H; Majima H; Niitani H; Ohta K; Wakui A; Nakao I; Tsukagoshi S
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1011-8. PubMed ID: 8687215
[TBL] [Abstract][Full Text] [Related]
4. [An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II].
Fukuoka M; Noda K; Hasegawa K; Nakajima H; Furuse K; Hirabayashi K; Hasegawa K; Ogura T; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1813-24. PubMed ID: 8937492
[TBL] [Abstract][Full Text] [Related]
5. Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II study.
Yokoyama A; Nakai Y; Yoneda S; Kurita Y; Niitani H
Anticancer Drugs; 1997 Jul; 8(6):574-81. PubMed ID: 9300571
[TBL] [Abstract][Full Text] [Related]
6. [Phase I study of gemcitabine hydrochloride (LY 188011) combination therapy with cisplatin in the patients with non-small cell lung cancer].
Kurita Y; Yokoyama A; Matsui K; Hara N; Nakai Y; Ohhashi Y; Niitani H
Gan To Kagaku Ryoho; 1999 Jun; 26(7):898-907. PubMed ID: 10396316
[TBL] [Abstract][Full Text] [Related]
7. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
Anderson H; Lund B; Bach F; Thatcher N; Walling J; Hansen HH
J Clin Oncol; 1994 Sep; 12(9):1821-6. PubMed ID: 8083706
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer.
Cho KH; Song YB; Choi IS; Cho EH; Choi JW; Ahn YM; Roh YH; Nam SH; Kim BS
Jpn J Clin Oncol; 2006 Jan; 36(1):50-4. PubMed ID: 16418187
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study.
Zatloukal P; Kanitz E; Magyar P; Jassem J; Krzakowski M; Pawlicki M; Petruzelka L; Chovan L; Pesek M; Janko C; Krejcy K
Lung Cancer; 1998 Dec; 22(3):243-50. PubMed ID: 10048477
[TBL] [Abstract][Full Text] [Related]
10. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
[TBL] [Abstract][Full Text] [Related]
12. Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15.
Cortesi E; Ramponi S; Corona M; Moscetti L; Grifalchi F; Oliva A; Lembo A; Gasperoni S; Padovani A
Lung Cancer; 2001; 31(2-3):271-6. PubMed ID: 11165407
[TBL] [Abstract][Full Text] [Related]
13. [Gemcitabine in the treatment of non-small cell lung cancer for elderly patients].
Furuse K
Gan To Kagaku Ryoho; 1999 Jun; 26(7):890-7. PubMed ID: 10396315
[TBL] [Abstract][Full Text] [Related]
14. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
[TBL] [Abstract][Full Text] [Related]
15. [Phase II studies of gemcitabine for non-small cell lung cancer in Japan].
Asai G; Fukuoka M
Gan To Kagaku Ryoho; 1999 Jun; 26(7):884-9. PubMed ID: 10396314
[TBL] [Abstract][Full Text] [Related]
16. A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.
Chen YM; Perng RP; Yang KY; Liu TW; Tsai CM; Ming-Liu J; Whang-Peng J
Chest; 2000 Jun; 117(6):1583-9. PubMed ID: 10858387
[TBL] [Abstract][Full Text] [Related]
17. Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
Takada M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Fukuoka M
Cancer Chemother Pharmacol; 1998; 41(3):217-22. PubMed ID: 9443638
[TBL] [Abstract][Full Text] [Related]
18. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
19. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
[TBL] [Abstract][Full Text] [Related]
20. A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule.
Kunikane H; Kurita Y; Watanabe K; Yokoyama A; Noda K; Fujita Y; Yoneda S; Nakai Y; Niitani H
Int J Clin Oncol; 2001 Dec; 6(6):284-90. PubMed ID: 11828947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
